Cyclowest partners with Tema Sinergie and Cyclomedica, for an hot cell line for FDG production at the new nuclear medicine center in Western Australia
Perth, Australia, welcomes the new Cyclowest
Nuclear Medicine
Tema Sinergie at SNMMI’23
From June 24th through 27th Tema Sinergie will attend the SNMMI Annual Meeting 2023 in Chicago. On booth #6049 of McCormik Place you will find a full range of technologies dedicated to Nuclear Medicine and Theranostic. Our staff will be available to introduce you to the most appropriate solutions to meet your needs. Get a […]
Terapie radiofarmaceutiche: una nuova frontiera
MRT, RPT, PRRT… comunque le si chiami, le moderne terapie di tipo radiofarmaceutico (RPT) hanno cominciato a rappresentare uno dei principali argomenti di discussione, confronto ed approfondimento alle recenti conferenze di Medicina Nucleare degli ultimi sei anni.
karl100.com is online! Check out our brand new website focused on KARL100
Introducing karl100.com, a brand new website completely focused on our radiopharmaceutical dose administration
Brand new PET/CT centre in the UK with KARL100 and Rad-Inject
From manual to automatic dipensing and injection at the Alliance Medical of Guildford. They will be able to increase the number of patients in a single day
Entrepreneurial partnership between Charme Capital Partners SGR S.p.A. and Tema Sinergie S.p.A.
Charme Capital Partners SGR S.p.A. and the shareholders of Tema Sinergie S.p.A. announce
Tema Sinergie presents VI, the new automatic visual inspection and vial labelling system for Nuclear Medicine
VI will be officially presented in Barcelona, during the next EANM